{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"5"}],"units":"Participants"}],"groups":[{"description":"IV pulse actinomycin-D (1.25mg/m2 ) every 14 days. (2mg max dose)","id":"OG000","title":"Regimen I (Dactinomycin)"},{"description":"institutional preference of either:\n\n* IV methotrexate (0.4 mg/kg) daily for 5 days every 14 days. (25mg max daily dose) OR\n* IM methotrexate (50mg) on Days 1, 3, 5, 7 (4 doses per cycle) with Leucovorin (15mg) on Days 2, 4, 6, 8. Repeat every 14 days.","id":"OG001","title":"Regimen II (Methotrexate)"}],"paramType":"NUMBER","populationDescription":"Non-responding eligible patients in follow-up","reportingStatus":"POSTED","timeFrame":"Anytime during post treatment follow-up for up to 2 years from study entry.","title":"The Number of Participants With Post Protocol Multi-agent Chemotherapy Treatment for Each Arm.","type":"SECONDARY","unitOfMeasure":"participants"}